What’s next in women’s health The biggest innovation opportunities for 2022

Summary for practice owners

This webinar surveys innovation opportunities across women’s health, including femtech, at home diagnostics and sexual health, as well as fertility, pregnancy and breast health. The speakers describe a market where consumer products, medical devices, digital services and clinical care increasingly overlap. They point to unmet needs and gaps in evidence, including the historic underrepresentation of women in research, and discuss how those gaps shape product development. The webinar is aimed at industry participants, but it offers practice owners a useful overview of areas that may bring new tools into clinical settings.

A recurring theme is the work required to turn an idea into a solution that can be adopted. Products need to address a real user need, fit a regulatory and commercial pathway, and account for reimbursement and affordability. In clinical settings, the speakers highlight workload and efficacy: a new tool should fit existing practice, reduce unnecessary complexity and demonstrate value to clinicians and users. Data access and interoperability remain barriers in several areas, while screening and monitoring, alongside personalized approaches offer possible development paths.

For OB-GYN owners, the webinar can inform vendor conversations and service planning. It maps areas worth watching and gives a set of practical evaluation questions: who is the intended user, what problem is being solved, what evidence supports the product, how does it fit a workflow, and who can access or pay for it? The broad scope means it does not evaluate a single product. Its value is helping practice leaders understand the commercial and operational context around new women’s health offerings before considering adoption or partnership.

Owner takeaways

• 3:44 The webinar frames its focus around future opportunities and commercial development in women’s health.
• 10:08 Speakers connect research gaps to the underrepresentation of women in clinical trials.
• 16:35 Companies face differing pathways as consumer health products move toward medical regulation.
• 20:54 At home diagnostics can span surveys, apps plus wearable devices, as well as testing.
• 42:08 New clinical tools need to fit current workflows and avoid adding unnecessary workload.

Why it made the list

The webinar maps emerging women’s health markets and the adoption hurdles that matter to practice owners. It has 759 views and 6 likes.

Related videos

The Business Of Fertility And Why It Took So Long

The Business of Gynecology in Canada w/ Dr. Jonathon Solnik | BackTable OBGYN Ep. 78

Panel 06: Fertility Inc.: Charting the Business of Reproduction

This video is published by LSX Leaders on YouTube. Obstetricians.com is not affiliated with the creator, and inclusion is not an endorsement by either party. Watch it on YouTube.